F Dong1, C X Fang, X Yang, X Zhang, F L Lopez, J Ren. 1. Division of Pharmaceutical Sciences and Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, 1000 E. University Avenue, Department 3375, Laramie, WY 82071, USA.
Abstract
AIMS/HYPOTHESIS: Insulin resistance leads to oxidative stress and cardiac dysfunction. This study examined the impact of catalase on insulin-resistance-induced cardiac dysfunction, oxidative damage and insulin sensitivity. METHODS: Insulin resistance was initiated in FVB and catalase-transgenic mice by 12 weeks of sucrose feeding. Contractile and intracellular Ca2+ properties were evaluated in cardiomyocytes including peak shortening (PS), time-to-PS (TPS), time-to-90% relengthening (TR90), half-width duration (HWD), maximal velocity of shortening/relengthening (+/-dL/dt), fura-fluorescence intensity change (DeltaFFI) and intracellular Ca2+ clearance rate (tau). Reactive oxygen species (ROS) and protein damage were evaluated with dichlorodihydrofluorescein and protein carbonyl formation. RESULTS: Sucrose-fed mice displayed hyperinsulinaemia, impaired glucose tolerance and normal body weight. Myocytes from FVB sucrose-fed mice exhibited depressed PS and +/-dL/dt, prolonged TR90 and tau, and reduced DeltaFFI associated with normal TPS and HWD compared with those from starch-fed control mice. ROS and protein carbonyl formation were elevated in FVB sucrose-fed mice. Insulin sensitivity was reduced, evidenced by impaired insulin-stimulated 2-deoxy-D: -[3H]glucose uptake. Western blot analysis indicated that sucrose feeding: (1) inhibited insulin-stimulated phosphorylation of insulin receptor and Akt; (2) enhanced protein-tyrosine phosphatase 1B (PTP1B) expression; and (3) suppressed endothelial nitric oxide synthase (eNOS) and Na+-Ca2+ exchanger expression without affecting peroxisome proliferator-activated receptor gamma (PPARgamma), sarco(endo)plasmic reticulum Ca2+-ATPase isozyme 2a and phospholamban. Catalase ablated insulin-resistance-induced mechanical dysfunction, ROS production and protein damage, and reduced eNOS, but not insulin insensitivity. Catalase itself decreased resting FFI and enhanced expression of PTP1B and PPARgamma. CONCLUSIONS/ INTERPRETATION: These data indicate that catalase rescues insulin-resistance-induced cardiac dysfunction related to ROS production and protein oxidation but probably does not improve insulin sensitivity.
AIMS/HYPOTHESIS: Insulin resistance leads to oxidative stress and cardiac dysfunction. This study examined the impact of catalase on insulin-resistance-induced cardiac dysfunction, oxidative damage and insulin sensitivity. METHODS: Insulin resistance was initiated in FVB and catalase-transgenic mice by 12 weeks of sucrose feeding. Contractile and intracellular Ca2+ properties were evaluated in cardiomyocytes including peak shortening (PS), time-to-PS (TPS), time-to-90% relengthening (TR90), half-width duration (HWD), maximal velocity of shortening/relengthening (+/-dL/dt), fura-fluorescence intensity change (DeltaFFI) and intracellular Ca2+ clearance rate (tau). Reactive oxygen species (ROS) and protein damage were evaluated with dichlorodihydrofluorescein and protein carbonyl formation. RESULTS:Sucrose-fed mice displayed hyperinsulinaemia, impaired glucose tolerance and normal body weight. Myocytes from FVB sucrose-fed mice exhibited depressed PS and +/-dL/dt, prolonged TR90 and tau, and reduced DeltaFFI associated with normal TPS and HWD compared with those from starch-fed control mice. ROS and protein carbonyl formation were elevated in FVB sucrose-fed mice. Insulin sensitivity was reduced, evidenced by impaired insulin-stimulated 2-deoxy-D: -[3H]glucose uptake. Western blot analysis indicated that sucrose feeding: (1) inhibited insulin-stimulated phosphorylation of insulin receptor and Akt; (2) enhanced protein-tyrosine phosphatase 1B (PTP1B) expression; and (3) suppressed endothelial nitric oxide synthase (eNOS) and Na+-Ca2+ exchanger expression without affecting peroxisome proliferator-activated receptor gamma (PPARgamma), sarco(endo)plasmic reticulum Ca2+-ATPase isozyme 2a and phospholamban. Catalase ablated insulin-resistance-induced mechanical dysfunction, ROS production and protein damage, and reduced eNOS, but not insulin insensitivity. Catalase itself decreased resting FFI and enhanced expression of PTP1B and PPARgamma. CONCLUSIONS/ INTERPRETATION: These data indicate that catalase rescues insulin-resistance-induced cardiac dysfunction related to ROS production and protein oxidation but probably does not improve insulin sensitivity.
Authors: Mihaela C Blendea; David Jacobs; Craig S Stump; Samy I McFarlane; Cristina Ogrin; Gul Bahtyiar; Samir Stas; Pawan Kumar; Quan Sha; Carlos M Ferrario; James R Sowers Journal: Am J Physiol Endocrinol Metab Date: 2004-10-19 Impact factor: 4.310
Authors: Eva Tomás; Yen-Shou Lin; Zeina Dagher; Asish Saha; Zhijun Luo; Yasuo Ido; Neil B Ruderman Journal: Ann N Y Acad Sci Date: 2002-06 Impact factor: 5.691
Authors: Kadon K Hintz; David P Relling; Jack T Saari; Anthony J Borgerding; Jinhong Duan; Bonnie H Ren; Kosai Kato; Paul N Epstein; Jun Ren Journal: Alcohol Clin Exp Res Date: 2003-07 Impact factor: 3.455
Authors: Jun Ren; Xiaochun Zhang; Glenda I Scott; Lucy B Esberg; Bonnie H Ren; Bruce Culver; Alex F Chen Journal: J Cardiovasc Pharmacol Date: 2004-02 Impact factor: 3.105
Authors: Karl D Pendergrass; Susan T Varghese; Kathryn Maiellaro-Rafferty; Milton E Brown; W Robert Taylor; Michael E Davis Journal: Circ Heart Fail Date: 2010-10-22 Impact factor: 8.790
Authors: Xiaodan Wang; Marko Z Vatamaniuk; Carol A Roneker; Matthew P Pepper; Liangbiao G Hu; Rebecca A Simmons; Xin Gen Lei Journal: Antioxid Redox Signal Date: 2010-09-29 Impact factor: 8.401
Authors: Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér Journal: Physiol Rev Date: 2016-01 Impact factor: 37.312
Authors: Jun Ren; Feng Dong; Guo-Jun Cai; Peng Zhao; Jennifer M Nunn; Loren E Wold; Jianming Pei Journal: PLoS One Date: 2010-04-09 Impact factor: 3.752